Results 11 to 20 of about 4,875,051 (314)

An Overview of Surgical Therapy for Movement Disorders

Proceedings of Singapore Healthcare, 2010
Surgical treatments are an important consideration in the management of many movement disorders, particularly for patients refractory to medications.
Kumar M Prakash MBBS, MMed (Internal Medicine), MRCP (UK), FRCP (Edin), FAMS (Neurology)
doaj   +1 more source

The Use of Procalcitonin in Clinical Practice

Proceedings of Singapore Healthcare, 2014
Procalcitonin (PCT) has emerged as the most promising marker of infectious inflammation. This development is critical to the practicing doctor dealing with febrile patients with suspected sepsis. An ideal biomarker would provide data for early diagnosis,
Clementine YF Yap MSc, MBA, DLM(ASCP), Tar Choon Aw MMed (Internal Medicine), FRCP (Edin), FRCPA   +1 more
doaj   +1 more source

Canadian Internal Medicine Ultrasound (CIMUS) consensus statement: recommendations for mandatory ultrasound competencies for ultrasound-guided thoracentesis, paracentesis, and central venous catheterization

The Ultrasound Journal
Objectives To develop a Canadian Internal Medicine Ultrasound (CIMUS) consensus statement on recommended mandatory point-of-care ultrasound (POCUS) competencies for ultrasound-guided thoracentesis, paracentesis, and central venous catheterizations (CVC ...
Canadian Internal Medicine Ultrasound
doaj   +1 more source

Internal Medicine [PDF]

, 2017
Our objective was to develop a model to predict the length of stay of patients using data from MCV. We conducted our analysis using a dataset of over 130,000 patients described by 66 features.
Hakem, Keroles, Trachy, Robert, Tran, Khanh   +2 more
core   +1 more source

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges, Kelly A. Duffy, Sara McDonough, Evelyn Kurpiewski, R. Jennifer Randall, Allison Barz Leahy, Haley M. Newman, Joyce P. Lee, Stephen P. Hunger, Anne F. Reilly, David T. Teachey, Susan R. Rheingold, Daniel J. Zheng   +12 more
wiley   +1 more source

A Balance of Interests: the Concordance of Copyright Law and Moral Rights in the Worldwide Economy [PDF]

, 2001
LECTURE IN INTERNAL MEDICINE ...
Bogun, L., Brynza, M., Bychkova, O., Lysenko, N., Martymianova, L., Yabluchansky, M.   +5 more
core   +1 more source

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács, Zoltán Köllő, Balázs Gellért Karvaly, Mahmoud Obeidat, Rita Nagy, Péter Hegyi, Brigitta Teutsch, Eszter Tuboly, Miklós Garami   +8 more
wiley   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul, Jatuporn Sujjitjoon, Pa‐thai Yenchitsomanus, Kridtin Jarutatsanangkoon, Ng Wei Loon, Kleebsabai Sanpakit, Jassada Buaboonnam, Chayamon Takpradit, Pornpimon Yuti, Nunghathai Sawasdee, Piriya Luangwattananun, Siripakorn Sangkitporn, Arnan Limmahachai, La‐ongsri Atchaneeyasakul   +13 more
wiley   +1 more source

Update in Internal Medicine [PDF]

Archives of Medical Research, 2000
More than 500,000 new medical articles are published every year and available time to keep updated is scarcer every day. Nowadays, the task of selecting useful, consistent, and relevant information for clinicians is a priority in many major medical journals.
F, López-Jiménez, M, Brito, Y W, Aude, P, Scheinberg, M, Kaplan, D A, Dixon, N, Schneiderman, J F, Trejo, L H, López-Salazar, E J, Ramírez-Barba, R, Kalil, C, Ortiz, J, Goyos, A, Buenaño, S, Kottiech, G A, Lamas   +15 more
openaire   +2 more sources

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego, Kellee Parker, William C. Thomsen, James B. Ford, Mallorie B. Heneghan, David Spencer Mangum, Jennifer L. McNeer, Luke D. Maese, Claire E. F. Miller, Richard Lemons, Taumoha Ghosh   +10 more
wiley   +1 more source